Dr. Meng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5200 Harry Hines Blvd
Dallas, TX 75235Phone+1 214-590-8000Fax+1 214-645-8769
Education & Training
University of Texas Southwestern Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2019 - 2021
NYU Grossman School of MedicineResidency, Urology, 2015 - 2019- NYU Grossman School of MedicineInternship, Surgery, 2014 - 2015
- New York University School of MedicineClass of 2014
Certifications & Licensure
TX State Medical License 2019 - 2026- American Board of Urology Urology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Clinical Trials
- Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma Start of enrollment: 2021 Nov 29
Publications & Presentations
PubMed
- 148 citationsRelationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion–targeted Prostate Biopsy OutcomesXiaosong Meng, Andrew B. Rosenkrantz, Neil Mendhiratta, Michael Fenstermaker, Richard Huang
European Urology. 2016-03-01 - 121 citationsOptimization of Prostate Biopsy: the Role of Magnetic Resonance Imaging Targeted Biopsy in Detection, Localization and Risk AssessmentMarc A. Bjurlin, Xiaosong Meng, Julien Le Nobin, James S. Wysock, Herbert Lepor
The Journal of Urology. 2014-09-01 - 67 citationsPrebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.Neil Mendhiratta, Xiaosong Meng, Andrew B. Rosenkrantz, James S. Wysock, Michael Fenstermaker
Urology. 2015-12-01
Press Mentions
Children’s Research Institute at UT Southwestern Scientists Discover Kidney Cancers Rely on Mitochondrial Metabolism to MetastasizeAugust 14th, 2024- UT Southwestern Pioneers New Minimally Invasive Treatment for Prostate CancerDecember 8th, 2022
Anti-VEGF Fails to Boost Overall Survival in Bladder CancerNovember 21st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
